Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 559,814 $ 402,415
Accounts receivable, net 282,313 280,271
Inventories 157,879 157,646
Prepaid expenses and other assets 590,148 472,816
Total current assets 1,590,154 1,313,148
Property and equipment, net 16,463,522 16,433,292
Goodwill 98,134 98,134
Trade names 500,525 500,525
Other long-term assets 1,172,853 1,147,891
Total assets 19,825,188 19,492,990
Current liabilities:    
Current portion of long-term debt 1,744,221 1,744,778
Accounts payable 204,971 174,338
Accrued expenses and other liabilities 1,019,620 1,058,919
Advance ticket sales 3,629,707 3,060,666
Total current liabilities 6,598,519 6,038,701
Long-term debt 12,005,296 12,314,147
Other long-term liabilities 859,282 839,335
Total liabilities 19,463,097 19,192,183
Commitments and contingencies (Note 9)
Shareholders' equity:    
Ordinary shares, $0.001 par value; 980,000,000 shares authorized; 429,025,827 shares issued and outstanding at March 31, 2024 and 425,546,570 shares issued and outstanding at December 31, 2023 429 425
Additional paid-in capital 7,708,869 7,708,957
Accumulated other comprehensive income (loss) (464,423) (508,438)
Accumulated deficit (6,882,784) (6,900,137)
Total shareholders' equity 362,091 300,807
Total liabilities and shareholders' equity $ 19,825,188 $ 19,492,990